Neuroleptic malignant-like syndrome and acute hepatitis during tolcapone and clozapine medication

被引:5
作者
Blum, MW
Siegel, AM
Meier, R
Hess, K
机构
[1] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland
关键词
D O I
10.1159/000050792
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:158 / 160
页数:3
相关论文
共 5 条
[1]   Tolcapone and fulminant hepatitis [J].
Assal, F ;
Spahr, L ;
Hadengue, A ;
Rubbici-Brandt, L ;
Burkhard, PR .
LANCET, 1998, 352 (9132) :958-958
[2]   Effect of liver impairment on the pharmacokinetics of tolcapone and its metabolites [J].
Jorga, KM ;
Kroodsma, JM ;
Fotteler, B ;
Heizmann, P ;
Meyer, J ;
Rasch, MC ;
van Hattum, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (06) :646-654
[3]  
Männistö PT, 1999, PHARMACOL REV, V51, P593
[4]   Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease [J].
Nutt, JG .
LANCET, 1998, 351 (9111) :1221-1222
[5]  
OERTEL WH, 1998, CLIN NEUROPHARMACOL, V21, P17